ATA Guidelines Tools

Thyroid Hormones

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1519086

Contents of this Issue

Navigation

Page 8 of 9

9 Laboratory mitigation Estimate of prevalence Method comparison — different antibody species/label. Immunosubtraction, e.g., polyethylene glycol (PEG) a precipitation. Linearity/dilution studies. Withdraw biotin and resample. Heterophile blocking reagents. Assay-dependent heterophile ~0.4% Method comparison — different antibody species/label. Equilibrium dialysis. Unknown Immunosubtraction, e.g., PEG precipitation. Linearity/dilution studies. Gel filtration chromatography. ~0.17% Method comparison with two-step method/ equilibrium dialysis. Immunosubtraction, e.g., PEG precipitation. 1.8% c Assay-dependent method comparison. Assay-specific allele frequency 0.13% (gnomAD v 2.1.1) Assay-dependent method comparison. Equilibrium dialysis. Alb, TRR gene sequencing Most common allele familial dysalbuminemic hyperthyroxinemia p.Arg242His 0.007% DTH p.Ala129Thr 0.003% (gnomAD v 2.1.1) d Predose sample, analyze immediately. Predose sample, exchange medication. Not available Assay specific

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Hormones